chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram carotid, Balance disorder, Brain oedema, Carotid artery occlusion, Cognitive disorder
Clinical narrative: Patient was admitted to the hospital 10/08/21 because after playing soccer he developed dizziness and left-sided weakness . On admission head CT showed large right MCA and small right ACA ischemic CVA with cytotoxic right basal ganglia edema . Head and neck CTA showed occlusion of right ICA at the level of ophthalmic artery. The patient was transferred to another hospital where he had thrombectomy.  Additional study was done TEE with did not reveal any shunt, did not reveal any valvular abnormalities.   Patient was consulted by neurologist with recommendation treat patient with aspirin, Plavix and statin Because of patient weakness, left-sided neglect, impaired mobility, ADLs he was consulted by PM&R service and decided he will benefit from comprehensive inpatient rehab program and on 10/24/2021 transfer to rehab hospital to start comprehensive inpatient rehab program.   Hospital Course: Principal Problem: Ischemic stroke (HCC) -recommended continue aspirin and Plavix  Ischemic CVA-EKG showed sinus rhythm but does not explain patient's stroke and cardiology recommended loop recorder after patient will be discharged what could be placed as outpatient  Cognitive deficit-patient still require minimal assistance for memory, moderate assistance for problem solving and recommended continue speech therapy as outpatient  Impaired balance with left hemiparesis-recommend continue AFO and standard cane for ambulation.  This is permanent left hemiparesis as of 2025.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Dizziness, Echocardiogram, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: Patient was admitted to the hospital 10/08/21 because after playing soccer he developed dizziness and left-sided weakness . On admission head CT showed large right MCA and small right ACA ischemic CVA with cytotoxic right basal ganglia edema . Head and neck CTA showed occlusion of right ICA at the level of ophthalmic artery. The patient was transferred to another hospital where he had thrombectomy.  Additional study was done TEE with did not reveal any shunt, did not reveal any valvular abnormalities.   Patient was consulted by neurologist with recommendation treat patient with aspirin, Plavix and statin Because of patient weakness, left-sided neglect, impaired mobility, ADLs he was consulted by PM&R service and decided he will benefit from comprehensive inpatient rehab program and on 10/24/2021 transfer to rehab hospital to start comprehensive inpatient rehab program.   Hospital Course: Principal Problem: Ischemic stroke (HCC) -recommended continue aspirin and Plavix  Ischemic CVA-EKG showed sinus rhythm but does not explain patient's stroke and cardiology recommended loop recorder after patient will be discharged what could be placed as outpatient  Cognitive deficit-patient still require minimal assistance for memory, moderate assistance for problem solving and recommended continue speech therapy as outpatient  Impaired balance with left hemiparesis-recommend continue AFO and standard cane for ambulation.  This is permanent left hemiparesis as of 2025.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Hemiparesis, Ischaemic stroke, Loss of personal independence in daily activities, Memory impairment, Middle cerebral artery stroke
Clinical narrative: Patient was admitted to the hospital 10/08/21 because after playing soccer he developed dizziness and left-sided weakness . On admission head CT showed large right MCA and small right ACA ischemic CVA with cytotoxic right basal ganglia edema . Head and neck CTA showed occlusion of right ICA at the level of ophthalmic artery. The patient was transferred to another hospital where he had thrombectomy.  Additional study was done TEE with did not reveal any shunt, did not reveal any valvular abnormalities.   Patient was consulted by neurologist with recommendation treat patient with aspirin, Plavix and statin Because of patient weakness, left-sided neglect, impaired mobility, ADLs he was consulted by PM&R service and decided he will benefit from comprehensive inpatient rehab program and on 10/24/2021 transfer to rehab hospital to start comprehensive inpatient rehab program.   Hospital Course: Principal Problem: Ischemic stroke (HCC) -recommended continue aspirin and Plavix  Ischemic CVA-EKG showed sinus rhythm but does not explain patient's stroke and cardiology recommended loop recorder after patient will be discharged what could be placed as outpatient  Cognitive deficit-patient still require minimal assistance for memory, moderate assistance for problem solving and recommended continue speech therapy as outpatient  Impaired balance with left hemiparesis-recommend continue AFO and standard cane for ambulation.  This is permanent left hemiparesis as of 2025.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Scan with contrast, Thrombectomy
Clinical narrative: Patient was admitted to the hospital 10/08/21 because after playing soccer he developed dizziness and left-sided weakness . On admission head CT showed large right MCA and small right ACA ischemic CVA with cytotoxic right basal ganglia edema . Head and neck CTA showed occlusion of right ICA at the level of ophthalmic artery. The patient was transferred to another hospital where he had thrombectomy.  Additional study was done TEE with did not reveal any shunt, did not reveal any valvular abnormalities.   Patient was consulted by neurologist with recommendation treat patient with aspirin, Plavix and statin Because of patient weakness, left-sided neglect, impaired mobility, ADLs he was consulted by PM&R service and decided he will benefit from comprehensive inpatient rehab program and on 10/24/2021 transfer to rehab hospital to start comprehensive inpatient rehab program.   Hospital Course: Principal Problem: Ischemic stroke (HCC) -recommended continue aspirin and Plavix  Ischemic CVA-EKG showed sinus rhythm but does not explain patient's stroke and cardiology recommended loop recorder after patient will be discharged what could be placed as outpatient  Cognitive deficit-patient still require minimal assistance for memory, moderate assistance for problem solving and recommended continue speech therapy as outpatient  Impaired balance with left hemiparesis-recommend continue AFO and standard cane for ambulation.  This is permanent left hemiparesis as of 2025.
Age: 0.25
Sex: F
Vaccine: HIBV
Symptoms: Screaming
Clinical narrative: Inconsolable screaming for 3 hours straight.  Starting about 3. 5 hours after vaccine given.
Age: 0.17
Sex: F
Vaccine: PNC20
Symptoms: Infant irritability, Pyrexia
Clinical narrative: 3 hours after vaccine, became fussy, clingy, febrile x 2 days.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Erythema, Injection site erythema, Injection site pain, Pruritus, Rash
Clinical narrative: raised, flat, red spots in a rash pattern on his abdomen; and his feet and hands were noticeably red; injection site on the left arm was noticeably red and appeared tender; raised, flat, red spots in a rash pattern on his abdomen; Viral reaction; injection site on the left arm was noticeably red and appeared tender; itching on his hands and feet; This spontaneous report was received from a consumer or other non-health professional and refers to a 4-year-old male patient (reporter's son).   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (DTAP/IPV) .  On 31-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y019173, expiration date: 27-Jun-2024) 0.5 mL in left Arm, diluted with sterile diluent (MERCK STERILE DILUENT) (indication, expiration date, and lot # were not reported) for prophylaxis.  On 02-Apr-2025 (also reported as this morning), the patient complained of itching on his hands and feet, and his feet and hands were noticeably red. The injection site on the left arm was noticeably red and appeared tender. He went to daycare as scheduled and was observed by his daycare teachers to behave normally all day, with continued reporting of his hands being itchy. Reporter reported these symptoms to his pediatric doctor, who advised her to keep an eye on it and schedule a follow up if we had concerns. In that evening reporter noted raised, flat, red spots in a rash pattern on his abdomen. The injection site on the left arm was more red and tender looking than in the morning. The rash did not seem to be making him uncomfortable, but she had a follow up virtual visit with his pediatrician to report the rash out of concern that it might be an allergic reaction to a vaccine component. The pediatrician advised that it did not appear to be an allergic reaction, but that it appeared to be a rash common with viral reactions. The pediatrician advised continued monitoring of the rash and to follow up if my son developed sores in or around his mouth or difficulty eating. At the reporting time, the outcome of the events was unknown.   The causal relationship between all the events and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was not provided.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Rash erythematous, Rash papular
Clinical narrative: raised, flat, red spots in a rash pattern on his abdomen; and his feet and hands were noticeably red; injection site on the left arm was noticeably red and appeared tender; raised, flat, red spots in a rash pattern on his abdomen; Viral reaction; injection site on the left arm was noticeably red and appeared tender; itching on his hands and feet; This spontaneous report was received from a consumer or other non-health professional and refers to a 4-year-old male patient (reporter's son).   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (DTAP/IPV) .  On 31-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y019173, expiration date: 27-Jun-2024) 0.5 mL in left Arm, diluted with sterile diluent (MERCK STERILE DILUENT) (indication, expiration date, and lot # were not reported) for prophylaxis.  On 02-Apr-2025 (also reported as this morning), the patient complained of itching on his hands and feet, and his feet and hands were noticeably red. The injection site on the left arm was noticeably red and appeared tender. He went to daycare as scheduled and was observed by his daycare teachers to behave normally all day, with continued reporting of his hands being itchy. Reporter reported these symptoms to his pediatric doctor, who advised her to keep an eye on it and schedule a follow up if we had concerns. In that evening reporter noted raised, flat, red spots in a rash pattern on his abdomen. The injection site on the left arm was more red and tender looking than in the morning. The rash did not seem to be making him uncomfortable, but she had a follow up virtual visit with his pediatrician to report the rash out of concern that it might be an allergic reaction to a vaccine component. The pediatrician advised that it did not appear to be an allergic reaction, but that it appeared to be a rash common with viral reactions. The pediatrician advised continued monitoring of the rash and to follow up if my son developed sores in or around his mouth or difficulty eating. At the reporting time, the outcome of the events was unknown.   The causal relationship between all the events and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was not provided.
Vaccine: HEPA
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional adverse event; expired dose of VAQTA was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 17-APR-2025, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) first dose, (exact dose administered, anatomical route of administration were not reported) (lot #X025482, who had been verified to be a valid lot number and expiration date reported and validated as 12-APR-2025) as prophylaxis (expired product administered).  No additional adverse event.
Age: 17.0
Sex: F
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: HCP called to report a female who received their first dose of GARDASIL 9 in August of 2024 at the age of 17 has not received any subsequent doses since.  No symptoms reported.  Caller did not have any other information to provide at the time of the; No additional adverse event reported; This spontaneous report was received from a pharmacist and refers to a 17-year-old female patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On an unspecified date in August 2024, the patient was vaccinated with first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), 0.5 mL (.5 ml), (lot # and expiration date were not reported) as prophylaxis, and had not received any subsequent doses since (inappropriate schedule of product administration).  No additional adverse event.
Vaccine: MMR, MMR, MMR, MMR, VARCEL, VARCEL, VARCEL, VARCEL
Symptoms: Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: No evidence of immunity to measles or varicella.; No evidence of immunity to measles or varicella.; Caller reported that patient  had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity. / boosters of VARIVAX in 2013 and MMR-II in 2015 following leukemia treatments.; This spontaneous report was received from a physician, regarding a 17-year-old patient of unknown gender. The patient's medical history and concomitant medication were not reported. Concurrent conditions included Leukemia (in remission).   On 2008, the patient was vaccinated with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), at a dose of 0.5 mL as prophylaxis in combination with sterile diluent. And also on the same year, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), also at a dose of 0.5 ml as prophylaxis in combination with sterile diluent (strengths, doses, schemes, routes and anatomical locations of administration, lot numbers and expiration dates were not reported). Then on 2013, the patient received a booster of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and on 2015 a booster of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), this following leukemia treatment. On an unspecified date, they ran titers on the patient for measles, mumps, rubella, and varicella. There was evidence of immunity to mumps and rubella, but no evidence of immunity to measles or varicella. Caller reported that patient had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity.  The outcome of the events was not provided. No symptoms reported.  The causal relationship between the events and suspect vaccines was not provided.
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; I got the vaccine honey but I still got them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I got the vaccine honey but I still got them). The outcome of the vaccination failure and shingles were not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 22-APR-2025 This case was reported by a patient via interactive digital media. The patient got the vaccine honey but still got them. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
Age: 15.0
Sex: M
Vaccine: COVID19, HPV9
Symptoms: Urticaria
Clinical narrative: Patient developed diffuse hives shortly after receiving the COVID and HPV vaccine. I saw him the morning after injaction adn the hives have persisted. No other symptoms.  Patient was diagnosed with atypical pneumonia at the visit he received the vaccines and was prescribed azithromycin. He had not yet taken the medication when the rash arose
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC15, RV5
Symptoms: Infant irritability, Pyrexia
Clinical narrative: High fever 4 hours after receiving vaccines at 6 mo. well visit. Fever of 103 and extreme fuzziness for greater than 3 hours.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Contusion, Pain in extremity
Clinical narrative: pt complains of arm pain. Patient returned a year later after vaccine was administered. Upon checking with patient's physician, physician stated pt has a severe arthritis. Also, noted at the time of reporting, pt had a greenish blue bruise.
Age: 13.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Fall
Clinical narrative: Patient was in the vaccine room with her mother and two younger sisters who were both getting the same vaccination. Patient seemed to be fine after I injected the vaccine. She then swapped a seat with her younger sister so the sister can vaccinated. The patient was watching me give the vaccine when she got lightheaded, dizzy and fell from the chair on the ground. I advised the mom to keep her hand under the patient's head. I monitored the patient for any allergic reaction and loss of consciousness while the store manager on duty called EMS. EMS took over from their and monitored the patient. After about 30minutes EMS team asked the parents if they want to take their daughter to the ER. Parents declined and said they will monitor her at home. The patient came back to the pharmacy with her dad the next night and seemed to be doing well.
Age: 60.0
Sex: F
Vaccine: MMR, PNC20, VARZOS
Symptoms: Wrong product administered
Clinical narrative: The patient was given the Shingrix vaccine instead of the MMR vaccine. After being notified of the mistake, she returned to the clinic and received the MMR vaccine.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Joint stiffness, Mobility decreased, Pain, X-ray
Clinical narrative: Stiffness in joint. Loss of mobility and extreme prolonged pain going well beyond normal timeframe.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: DTap, Hep B, Polio combination (Pediarix) given incorrectly in place of single DTaP.  No treatment given. Per conversation with client's mother on 4/28/25, child had no symptoms/signs of adverse reaction post vaccination.
Age: 33.0
Sex: F
Vaccine: YF, YF
Symptoms: Chills, Cough, Dyspnoea, Headache, Vomiting
Clinical narrative: Pt started having shortness of breath and coughing a few hours after receiving the vaccine a rescue inhaler has been ineffective. Pt had one episode of vomiting the next day. Mild chills and intermittent headache noted.
Age: 33.0
Sex: F
Vaccine: YF, YF
Symptoms: Asthma, Chills, Condition aggravated, Cough, Dyspnoea
Clinical narrative: Pt started having shortness of breath and coughing a few hours after receiving the vaccine a rescue inhaler has been ineffective. Pt had one episode of vomiting the next day. Mild chills and intermittent headache noted.
Age: 33.0
Sex: F
Vaccine: YF, YF
Symptoms: Headache, Vomiting
Clinical narrative: Pt started having shortness of breath and coughing a few hours after receiving the vaccine a rescue inhaler has been ineffective. Pt had one episode of vomiting the next day. Mild chills and intermittent headache noted.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: pt states that the same day the injection site became the size of a quarter then it kept growing. After about 3 weeks it was about 4" x 3" in size. It was red, hot hard and very painful. She contacted the pharmacy and was told to report it.  It took about 4 months for it to completely disappear. She will contact her PCP about getting getting second dose.
Age: 46.0
Sex: F
Vaccine: HPV9, MMR
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was too old to receive HPV vaccine; no adverse events reported or noted.
Age: 50.0
Sex: M
Vaccine: HPV9, MMR
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient was over the recommended age limit for HPV vaccine; no adverse events reported or noted
Age: 46.0
Sex: M
Vaccine: HPV9, MMR
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was over the recommended age for HPV vaccine; no adverse events reported or noted.
Age: 1.17
Sex: M
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: none
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: I was told I was being given a tetanus shot it was not explained to me they were giving me the combination shot that included pertussis. I have never received the pertussis vaccination and even had a note in my file as a child that said I needed to be kept home if there was an outbreak of whooping cough. I did not consent to receiving the TDAP vaccination and would not have consented to receiving it. If they did not have the Td vaccine in the hospital I would have completely declined the vaccine as what caused my wound does not have a high risk for tetanus. I realized I was given the incorrect vaccine about 7 hours after when I was reading my discharge papers, I contacted the hospital who said they would do their own investigation to find out why I was not told what medication I was being given but of course there is no way to take back the vaccine.
Age: 29.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site pain
Clinical narrative: pain and soreness at injection site continues 26 days after administration
Age: 20.0
Sex: F
Vaccine: HEPA
Symptoms: Hypotension, Muscle tightness, Seizure like phenomena, Syncope, Unresponsive to stimuli
Clinical narrative: Patient reported prior to receiving the vaccine that she has fainted before/during vaccines. Vaccine was administered around 11:10am. After the vaccine was administered, within a minute (11:12am) she started to faint/appeared to almost be seizing rather than a full dead-weight drop (tensed up in the arms of the pharmacist/technican attending to her). The patient was shaken in an attempt to wake her, however, she was not responsive. When she came to she stated she was "okay" but continued to fade in and out. She was laid on the floor as to follow vaccine training until paramedics arrived. Paramedics arrived by 11: 25am and checked her vitals. They found her blood pressure was low (unknown specific value) and took her on the stretcher to ensure that she would get the proper approval that she is okay.  Further reactions unknown.
Age: 64.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Ear pain, Feeling abnormal, Headache, Pruritus
Clinical narrative: Patient received the vaccination on 4/28/25 at 4:00PM.  After receiving MMR  vaccination dose number 1.  about 5 minutes afterwards she stated, " I don't feel right ".  She then stated, " I feel fuzzy in the head".  I assisted her to the exam table and laid her in supine position. Vitals taken every 5 minutes were stable and consistent with no fluctuations present. No visible rashes present on body or chest.   Reported no shortness of breath, chest pain, difficulty breathing, nausea, or vomiting.  NO swelling of face, lips or tongue noted.  She reported that she was feeling better and wanted to drive home.   She called the following day on 4/29/25 at 8:30AM and stated she had to go to the emergency room last night at 10:00PM because she was having chest tightness and feeling short of breath.  She also reported severe headache, left ear pain and itchiness in the right ear and runny nose.  States after receiving steroid injection in the ER she felt itchiness in the vaginal area and rectum. She was reportedly seen in the emergency room prescribed steroids and was sent home afterwards and reported she was feeling better. She states she is still experiencing mild headaches and feeling dizzy.  She was advised by our provider to follow up with her PCP and if it persists return to the emergency room
Age: 64.0
Sex: F
Vaccine: MMR
Symptoms: Rhinorrhoea, Vulvovaginal pruritus
Clinical narrative: Patient received the vaccination on 4/28/25 at 4:00PM.  After receiving MMR  vaccination dose number 1.  about 5 minutes afterwards she stated, " I don't feel right ".  She then stated, " I feel fuzzy in the head".  I assisted her to the exam table and laid her in supine position. Vitals taken every 5 minutes were stable and consistent with no fluctuations present. No visible rashes present on body or chest.   Reported no shortness of breath, chest pain, difficulty breathing, nausea, or vomiting.  NO swelling of face, lips or tongue noted.  She reported that she was feeling better and wanted to drive home.   She called the following day on 4/29/25 at 8:30AM and stated she had to go to the emergency room last night at 10:00PM because she was having chest tightness and feeling short of breath.  She also reported severe headache, left ear pain and itchiness in the right ear and runny nose.  States after receiving steroid injection in the ER she felt itchiness in the vaginal area and rectum. She was reportedly seen in the emergency room prescribed steroids and was sent home afterwards and reported she was feeling better. She states she is still experiencing mild headaches and feeling dizzy.  She was advised by our provider to follow up with her PCP and if it persists return to the emergency room
Age: 20.0
Sex: M
Vaccine: FLU3, HEP, TDAP
Symptoms: Loss of consciousness, Pallor
Clinical narrative: Patient denied having syncope in the past. No records of vaccinations, in state database nor that patient brought. Flu, Tdap and Heplisav-B #1 vaccines administered. Tolerated well despite anxiety with needles. After administering the vaccines, venous blood collection began. During blood collection, patient passed out as 1st (of 2 vials were being collected). Right before he passed out, stated, "I feel like I'm going to pass out." Then immediately his skin turned pale and started sliding down out of the phlebotomy chair. Needle taken out  safely after tourniquet was removed. Ensured patient was safe and did not slide out of chair while calling for more assistance. 1 more RN and 1 MA arrived. Ammonia towelette used on patient who continued to slide out of chair, so he was lowered to the ground in a sitting position against the chair/cabinet, and his body convulsed a couple of times. We supported his head so it didn't hit against the cabinet/chair. Within 20-30 seconds, patient regained consciousness. Patient states he did not eat yet that day. Patient was assisted to lie down on yoga mat. Color gradually came back and then pale again with repeated bouts of nausea. Emesis x3-5 after attempting to drink some water and eating 1 graham cracker. Patient stayed in employee health clinic until his Grandma was able to come get him roughly 40 min. after he contacted her to pick him up. Patient was assisted to Grandma's suv by MA and RN who administered the vaccines and was doing the blood draw. Wheelchair was used to safely bring patient to Grandma's suv. Instructed Grandma to seek medical care/call 911 if needed if patient's nausea didn't improve and he was still light headed. The following day (4/23,) patient was "almost back to 100% with a tiny bit of nausea." Patient reports being able to keep food down since the night before (4/22).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Fatigue, Feeling jittery, Head injury, Injection site erythema
Clinical narrative: She noticed her arm was red from the injection site almost to her elbow (COVID Arm). She is very tired. She felt jittery on the inside. On 4/25/25 Patient fell in the early AM hit her head and knee (not sure if this is related to her vaccine).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Joint injury
Clinical narrative: She noticed her arm was red from the injection site almost to her elbow (COVID Arm). She is very tired. She felt jittery on the inside. On 4/25/25 Patient fell in the early AM hit her head and knee (not sure if this is related to her vaccine).
Age: 0.83
Sex: M
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Incorrect Vaccine administered.  Treatment:  Tylenol
Age: 28.0
Sex: F
Vaccine: TYP
Symptoms: Disturbance in attention, Vision blurred
Clinical narrative: Client called office after taking 1 dose of oral typhoid complaining of blurry vision and inability to stay focused.  Client advised to stop medication and to seek out medical treatment from PCP or ER
Age: 23.0
Sex: M
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Ped dose instead of adult dose
Age: 27.0
Sex: M
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: Ped dose instead of adult dose
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Fatigue, Headache, Malaise, Oropharyngeal pain, Sneezing
Clinical narrative: mom called the day after and said that pt got "very sick", she started with sneezing, sore throat, having a headache and feeling tired about 4-5 hours after vaccine injection. No reaction site pain. no lethargy. no difficulty breathing
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Cough, Headache
Clinical narrative: Pt was already reporting a slight cough, thought to be related to allergies. The next day after injection, the mom called our clinic and was worried that pt was coughing and having a headache. No injection site reaction. no severe difficulty breathing.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored inappropriately
Age: 19.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: This was an administration error.  The patient was given MMRV and this vaccine is suppose to be given from 12  months of age to 12 years. Patient did not experience any adverse events.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC20, RV1
Symptoms: Autopsy, Death, Sudden infant death syndrome, Toxicologic test
Clinical narrative: 04172025.  Autopsy and toxicology pending.  Presumed SIDS
Age: 38.0
Sex: F
Vaccine: HPV9
Symptoms: Limb mass, Pain in extremity, Peripheral swelling, Tenderness
Clinical narrative: Has been 4 weeks and the patient is still having significant arm pain. Swollen and painful to touch, feels like a lump under the skin.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine expired as of 12.4.25. Not as effective after expiration date.
Age: 0.58
Sex: M
Vaccine: MENB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: There was a mistake in documentation and the vaccine dose #3 in the series was given early. Was due 7/26, and was given 4/26.
Age: 41.0
Sex: F
Vaccine: DTAP
Symptoms: Dizziness, Exposure during pregnancy, Fatigue, Hot flush, Tachycardia
Clinical narrative: Tachycardia, hot flashes, fatigue, dizziness - 30 weeks pregnant
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Expiration date was 24 April 2025, administered today in error.  No adverse reaction to patient.
Age: 0.5
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine Expired. One given 1.15.25 and other on 4.9.25
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Pain, Pruritus
Clinical narrative: PATIENT CAME TO THE PHARMACY 3 DAYS AFTER RECEIVING THE SHOT.  I DID OBSERVE MULTIPLE RED PATCHES  OUTSIDE THE INJECTION SITE. SHE REPORTED FEELING SORENESS AND PAIN THE EVENING OF THE SHOT. THE REDNESS EXTENDED BEYOND THE INJECTION SITE WITH PAIN AND ITCHNESS TWO DAYS AFTER.  SHE ALREADY STARTED ON BENADRYL TABLET AT TIME OF REPORTING THIS INCIDENCE ON 4/28/25.  I RECOMMENDED USING BENADRYL CREAM AS WELL. I FOLLOEWD UP WITH HER TODAY 4/29/25  AND SHE IS STILL EXPERINCING THE REACTION. I CALLED HER DR AND THEY CONTACTED HER AND SCHEDULLED A VISIT WITH HER THIS AFTERNOON
Age: 3.0
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Pt's vaccine record was assessed by PHN and determined that patient was due for MMR, Varicella, Hepatitis A, Hepatitis B, and PCV vaccines. At the time of vaccine preparation, IPV vaccine prepared instead of Hepatitis B vaccine.  Error was not caught by PHN until documenting at which time patient had already received the incorrect vaccine.  Pt did not have any signs or symptoms after vaccine administration.  Parents were called around 15-20 minutes following vaccine administration and pt was given correct Hepatitis B vaccine.
Age: 51.0
Sex: F
Vaccine: PNC21
Symptoms: Lymphadenitis, Nausea, Vertigo, Vomiting
Clinical narrative: Severe inflammation of lymph nodes for 1 week. When this calmed down after 1 week, then developed severe vertigo that causes nausea/ vomiting. Currently the vertigo is being evaluated by ENT.
Age: 49.0
Sex: F
Vaccine: HEPAB, MMR, PNC20
Symptoms: Dizziness, Loss of consciousness, Urinary incontinence
Clinical narrative: The patient received three vaccines. Shortly after administration (around 5 minutes), patient felt dizzy and sat down on benches near customer service. She then passed out and slipped onto the floor. The patient lost control of bladder but quickly regained consciousness. The life squad was called for evaluation, and the patient went with them to the hospital to be further checked out.
Age: 64.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Erythema, swelling, pruritis at injection site beginning the day after vaccination. Lasted for several days.
Age: 61.0
Sex: F
Vaccine: PNC20, TDAP
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Left arm red, swollen and warm to touch. Improving since last week.
Age: 9.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: No adverse event
Clinical narrative: no symptoms
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Rash morbilliform
Clinical narrative: Measles_like spots that began on instep of @ foot.. Dr was seen 1/4/23 , could not DX. Blothced <typical on both legs rose to knee caps and to a much lesser degree to thighs ,hips , inside forearms..was mistakenly DX'd as livedo reicularis,,6/29/23 @facility DX'd  as LGL.. Sought assistance @another facility 8/1/23. ,referred to Hospital  for Special Surgery hematologist
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site abscess, Injection site discharge, Injection site swelling
Clinical narrative: MOM DESCRIBED PT HAVING AN ABSCESS AT THE SITE OF THE INJECTION.  MOM ALSO REPORTED THAT PT HAD SWELLING.  MOM WAS ABLE TO EXPRESS YELLOW EXUDATE FROM SITE
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Asthenia, Dizziness, Gait disturbance, Headache
Clinical narrative: Progressive weakness, dizziness, mild headaches, unsteady walk
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain fog, Chills, Computerised tomogram, Dyspnoea, Fatigue
Clinical narrative: Severe Pain in my hands.  Chills were so bad, I couldn't put on enough layers plus I went to bed under blankets.  Breathing difficulty. Headaches. Severe Fatigue.  Brain Fog I had breathing spells for about a year after.  Went to Pulmonlogist could not replicate. I continue to have days that I feel sick but not.  I have had covid so many times since that I can't count.  To this day I suffer from Severe fatigue and hand pain to the point I can't use my hands without pain.  It is making it hard for me to work.  I almost have had wrecks because of my brain.  I have been in Sales all my career and required to drive from client to client.  In the last 5 days I have been severely fatigue 3 out of the 5.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Impaired driving ability, Impaired work ability, Malaise, Pain in extremity
Clinical narrative: Severe Pain in my hands.  Chills were so bad, I couldn't put on enough layers plus I went to bed under blankets.  Breathing difficulty. Headaches. Severe Fatigue.  Brain Fog I had breathing spells for about a year after.  Went to Pulmonlogist could not replicate. I continue to have days that I feel sick but not.  I have had covid so many times since that I can't count.  To this day I suffer from Severe fatigue and hand pain to the point I can't use my hands without pain.  It is making it hard for me to work.  I almost have had wrecks because of my brain.  I have been in Sales all my career and required to drive from client to client.  In the last 5 days I have been severely fatigue 3 out of the 5.
Age: 53.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Diarrhoea, Erythema, Tenderness
Clinical narrative: diarrhea, tenderness and redness of arm down to elbow for last 2 days
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient is a 27-year-old female who was 35.3 weeks pregnant This patient received 2 TDAP doses in a 6-week time frame. The first dose administered on 3/7/25 and the second was given on 4/24/25. Patient did not have a reaction to the 2nd TDAP. Patient was called on 4/29/25 and all was well.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Extra dose administered
Clinical narrative: Give mmrv Already receive 2 doses of MMR
Age: 0.5
Sex: F
Vaccine: HIBV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was mistakely given an extra dose of PedvaxHib  at her 6 month well check.  No adverse event has been reported. This VAERS entry is FYI due to extra vaccine administered.
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Loss of consciousness
Clinical narrative: passed out. cool wet cloth, sips of water, doctor evaluation, recovery time 20-30 minutes. left clinic in stable condition with parent
Age: 54.0
Sex: F
Vaccine: PNC21, TDAP
Symptoms: Headache, Malaise, Vomiting
Clinical narrative: Patients husband came by and ask if it was normal for a patient to get sick after receiving vaccines- he said the patient had a headache and was throwing up.
Age: 80.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was given an additional dose of RSV vaccine. No adverse reactions reported by patient.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Patient complained of ear being hot to the touch
Age: 18.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: NONE- third dose was given to patient. Patient was only supposed receive two dose of vaccine.  I referred to database to find patients current vaccination needs. Database had duplicate accounts for patient due to recent name change. Database used indicated patient was due for HPV vaccine. Vaccine was administered.  Pt has not had adverse reaction up to  this point.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered Expired Covid 19 (Comirnaty) expired 04/07/2025 by mistake
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: pt received 2nd dose shingix 19 days early, no reaction at this time; pt to communicate with pharmacy should anything come up
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered expired Covid 19 (Comirnaty) expired 04/07/2025 by mistake
Age: 23.0
Sex: F
Vaccine: HEP, HPV9
Symptoms: Back pain, Pain
Clinical narrative: shooting lower back pain when turning. Patient reports getting better the next day. advised tyelonol and ibuprofen, if getting worse or continuing then reach out PCP
Age: 63.0
Sex: F
Vaccine: MMR
Symptoms: Psoriasis, Rash, Urticaria
Clinical narrative: urticarial rash to upper arms,  then psoriatic patches on hands, then urticarial rash to neck, chest and legs.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Dementia Alzheimer's type, Magnetic resonance imaging, X-ray
Clinical narrative: Diagnosed with Alzheimer's, currently in drug trials
Age: 1.25
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Muscle spasms
Clinical narrative: Injection site redness. Swelling. Right arm spasms.
Age: 0.83
Sex: F
Vaccine: IPV
Symptoms: Rash, Rash erythematous
Clinical narrative: Less than 48 hours after the vaccine was administered our child developed a rash, it was generalized across her entire body. Small red, raised bumps. We saw the pediatrician who said to wait a week and it should go away. When it didn?t we saw a pediatric dermatologist who said it could be vaccine related and otherwise could not explain it. They suggested applying a steroid cream. The rash has persisted and it has been approximately 6 weeks now.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Brain operation, Neuralgia
Clinical narrative: Patient developed trigeminal nerve pain 1 week after received vaccine and had to go through brain  surgery 11 month after.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, PNC20
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Extremely swollen upper thigh, injection sights visible for 5 days, hot to touch, painful for baby for 5 days
Age: 65.0
Sex: M
Vaccine: PNC20, PNC13
Symptoms: Bursitis, Pain
Clinical narrative: When I received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement.; inflammatory reaction/into the right  subacromial bursa; This is a spontaneous report received from a Physician.  A 65-year-old male patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), on 22Mar2025 at 13:00 as dose 1, single (Batch/Lot number: unknown) at the age of 65 years, in right upper arm for immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "reactive airways disease" (unspecified if ongoing); "allergy: Latex" (unspecified if ongoing); "Allergy: sulfa" (unspecified if ongoing); "pneumonia" (unspecified if ongoing), notes: two times in the last 18 months. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "allergy". The following information was reported: INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious) with onset 22Mar2025, outcome "recovering", described as "When I received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement."; VACCINATION SITE INFLAMMATION (non-serious) with onset 22Mar2025, outcome "recovering", described as "inflammatory reaction/into the right  subacromial bursa". Therapeutic measures were taken as a result of vaccination site inflammation  Additional information: When he received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement. Due to the inflammatory reaction, he was treated with a subacromial inaction of triamcinolone into the right subacromial bursa on 24Mar2025. He received a 4 mg Medrol dosepak on  28Apr2025 for 6 days of treatment. None of this was the fault of Pfizer.
Age: 65.0
Sex: M
Vaccine: PNC20, PNC13
Symptoms: Incorrect route of product administration, Injection site inflammation, Product administered at inappropriate site
Clinical narrative: When I received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement.; inflammatory reaction/into the right  subacromial bursa; This is a spontaneous report received from a Physician.  A 65-year-old male patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), on 22Mar2025 at 13:00 as dose 1, single (Batch/Lot number: unknown) at the age of 65 years, in right upper arm for immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "reactive airways disease" (unspecified if ongoing); "allergy: Latex" (unspecified if ongoing); "Allergy: sulfa" (unspecified if ongoing); "pneumonia" (unspecified if ongoing), notes: two times in the last 18 months. There were no concomitant medications. Past drug history included: Ceclor, reaction(s): "allergy". The following information was reported: INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious) with onset 22Mar2025, outcome "recovering", described as "When I received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement."; VACCINATION SITE INFLAMMATION (non-serious) with onset 22Mar2025, outcome "recovering", described as "inflammatory reaction/into the right  subacromial bursa". Therapeutic measures were taken as a result of vaccination site inflammation  Additional information: When he received the Prevnar injection, it was inadvertently injected into the subacromial bursa, not the deltoid due to poor injection placement. Due to the inflammatory reaction, he was treated with a subacromial inaction of triamcinolone into the right subacromial bursa on 24Mar2025. He received a 4 mg Medrol dosepak on  28Apr2025 for 6 days of treatment. None of this was the fault of Pfizer.
Age: 18.0
Sex: F
Vaccine: HPV9
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse event; HCP calling to report TE's for GARDASIL 9 advised the vaccine was administered to a patient on 03/11/2025. The GARDASIL 9 experienced two separate TE's before being administered.; This spontaneous report was received from a Consumer or other non health professional and refers to an 18-year-old female patient.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 11-Mar-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) lot #1957404, which was confirmed to be valid, expiration date: 05-Oct-2025 (dose, units, and route of administration were not reported) for prophylaxis. It was reported that the vaccine experienced two separate temperature excursions (TE's) before being administered (Product storage error). Temperature on 29-JAN-2025 was 35.8 F, and on 30-JAN-2025, it was 35.6 F for the time frame of 15 minutes and 10 minutes. No additional details were provided. There was no additional AE/PQC reported (No adverse event).